WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 7, 2017, Pages 1922-1929

  Roer, Louise ^a   Hansen, Frank ^a   Frølund Thomsen, Martin Christen ^b   Knudsen, Jenny Dahl ^c   Hansen, Dennis Schrøder ^d   Wang, Mikala ^e   Samulioniené, Jurgita ^f   Justesen, Ulrik Stenz ^g   Røder, Bent L ^f   Schumacher, Helga ^h   Østergaard, Claus ⁱ   Andersen, Leif Percival ^j   Dzajic, Esad ^k   Søndergaard, Turid Snekloth ^l   Stegger, Marc ^a   Hammerum, Anette M ^a   Hasman, Henrik ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

^g ODENSE UNIVERSITY HOSPITAL   (Denmark)

^h SLAGELSE HOSPITAL   (Denmark)

ⁱ LILLEBAELT HOSPITAL   (Denmark)

^j University of Copenhagen   (Denmark)

^k Hospital South West Jutland ^*  (Denmark)

^l VIBORG HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; EXTENDED SPECTRUM BETA LACTAMASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHILD; DENMARK; ESCHERICHIA COLI; FEMALE; FIMH GENE; HUMAN; INFANT; MALE; MULTILOCUS SEQUENCE TYPING; NEWBORN; NONHUMAN; PHYLOGENETIC TREE; PHYLOGENY; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE GENOME SEQUENCING; BACTEREMIA; BACTERIAL GENOME; BIOSYNTHESIS; CEPHALOSPORIN RESISTANCE; DRUG EFFECTS; ENZYMOLOGY; EPIDEMIOLOGICAL MONITORING; ESCHERICHIA COLI INFECTION; GENETICS; HIGH THROUGHPUT SEQUENCING; HORIZONTAL GENE TRANSFER; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGICAL MONITORING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE TRANSFER, HORIZONTAL; GENOME, BACTERIAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; POLYMERASE CHAIN REACTION;

EID: 85021844230     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx092     Document Type: Article

References (32)

1. ECDC. Antimicrobial Resistance Surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC, 2015. http://ecdc.europa.eu/en/publications/publications/ antimicrobial-resistance-europe-2014.pdf.
2. ECDC. Antimicrobial Resistance Surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC, 2013. http://ecdc.europa.eu/en/publications/Publications/ antimicrobial-resistance-surveillance-europe-2012.pdf.
3. Skjøt-Rasmussen L, Olsen SS, Jensen US et al. Increasing consumption of antimicrobial agents in Denmark parallels increasing resistance in Escherichia coli bloodstream isolates. Int J Antimicrob Agents 2012; 40: 86-8.
4. DANMAP 2015-Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria From Food Animals, Food and Humans in Denmark. http://www.danmap.org/~/media/Projekt%20sites/Danmap/ DANMAP%20reports/DANMAP%20%202015/DANMAP%202015.ashx.
5. Nicolas-Chanoine M-H, Bertrand X, Madec J-Y. Escherichia coli ST131, an intriguing clonal group. ClinMicrobiol Rev 2014; 27: 543-74.
6. HammerumAM, Hansen F, Nielsen HL et al. Use ofWGS data for investigation of a long-term NDM-1-producing Citrobacter freundii outbreak and secondary in vivo spread of blaNDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca. J Antimicrob Chemother 2016; 71: 3117-24.
7. Zankari E, Hasman H, Cosentino S et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012; 67: 2640-4.
8. Clausen PT, Zankari E, Aarestrup FM et al. Benchmarking of methods for identification of antimicrobial resistance genes in bacterial whole genome data.JAntimicrobChemother 2016; 71: 2484-8.
9. Hansen F, Olsen SS, Heltberg O et al. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. Microb Drug Resist 2014; 20: 316-24.
10. Larsen MV, Cosentino S, Rasmussen S et al.Multilocus sequence typing of total-genome-sequenced bacteria. JClinMicrobiol 2012; 50: 1355-61.
11. WirthT, FalushD, LanRet al. Sex and virulence in Escherichia coli: anevolutionary perspective. MolMicrobiol 2006; 60: 1136-51.
12. Jaureguy F, Landraud L, Passet V et al. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 2008; 9: 560.
13. Joensen KG, Tetzschner AMM, Iguchi A et al. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. JClinMicrobiol 2015; 53: 2410-26.
14. Weissman SJ, Johnson JR, Tchesnokova V et al. High-resolution twolocus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 2012; 78: 1353-60.
15. Price MN, Dehal PS, Arkin AP. FastTree 2-approximately maximumlikelihood trees for large alignments. PLoS One 2010; 5: e9490.
16. Zhou XY, Bordon F, Sirot D et al. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or anOXA-1 b-lactamase conferring resistance to b-lactamase inhibitors. Antimicrob Agents Chemother 1994; 38: 1085-9.
17. DANMAP 2014-Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria From Food Animals, Food and Humans in Denmark. http://www.danmap.org/~/media/Projekt sites/Danmap/DANMAP reports/DANMAP 2014/Danmap_2014.ashx.
18. DANMAP 2011-Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria From Food animals, Food and Humans in Denmark. http://www.danmap.org/~/media/Projekt sites/Danmap/DANMAP reports/Danmap_2011.ashx.
19. Peirano G, Pitout JDD. Molecular epidemiology of Escherichia coli producing CTX-M b-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316-21.
20. Sherchan JB, Hayakawa K,Miyoshi-Akiyama T et al. Clinical epidemiology and molecular analysis of extended-spectrum-b-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648. Antimicrob Agents Chemother 2015; 59: 3424-32.
21. Hristea A, Olaru ID, Adams-Sapper S et al. Characterization of ESBLproducing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study. Infect Dis (Lond) 2015; 47: 46-51.
22. PietschM, Eller C, Wendt C et al. Molecular characterisation of extendedspectrum b-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany. VetMicrobiol 2017; 200: 130-7.
23. Gerhold G, Schulze MH, Gross U et al. Multilocus sequence typing and CTX-M characterization of ESBL-producing E. coli: a prospective single-centre study in Lower Saxony, Germany. Epidemiol Infect 2016; 144: 3300-4.
24. Zhao S-Y,Wang Y-C, Xiao S-Z et al. Drug susceptibility andmolecular epidemiology of Escherichia coli in bloodstream infections in Shanghai, China, 2011-2013. Infect Dis (Lond) 2015; 47: 310-8.
25. Jean S-S, Hsueh P-R; on behalf of the SMART Asia-Pacific Group. Distribution of ESBLs, AmpC b-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother 2017; 72: 166-71.
26. Riley LW. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin Microbiol Infect 2014; 20: 380-90.
27. Adams-Sapper S, Diep BA, Perdreau-Remington F et al. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob Agents Chemother 2013; 57: 490-7.
28. Zhang J, Zheng B, Zhao L et al.Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with communityonset infections in Chinese county hospitals.BMCInfect Dis 2014; 14: 659.
29. Xia S, Fan X, Huang Z et al. Dominance of CTX-M-type extended-spectrum b-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China. PLoS One 2014; 9: e100707.
30. Tong P, Sun Y, Ji X et al. Characterization of antimicrobial resistance and extended-spectrum b-lactamase genes in Escherichia coli isolated from chickens. Foodborne Pathog Dis 2015; 12: 345-52.
31. Holmes A, Allison L,Ward Met al. Utility of whole-genome sequencing of Escherichia coli O157 for outbreak detection and epidemiological surveillance. J ClinMicrobiol 2015; 53: 3565-73.
32. Price LB, Johnson JR, AzizMet al. The epidemic of extended-spectrum-blactamase- producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H 30-Rx. MBio 2013; 4: e00377-13.